JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stone, C. A.
Right arrow Articles by Loew, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, C. A.
Right arrow Articles by Loew, E. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 106, Issue 2, 226-234, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


SPECIFICITY AND POTENCY OF ARYL-HALOALKYLAMINE ADRENERGIC BLOCKING DRUGS AS DETERMINED ON ISOLATED SEMINAL VESICLES OF GUINEA PIGS

Clement A. Stone 1 and Earl R. Loew 1

1 Department of Physiology, Boston University School of Medicine, Boston

The relative ability of various aryl-2-haloalkylamine adrenergic blocking drugs to block the spasmogenic effects of equi-effective doses of epinephrine, norepinephrine, histamine, and acetylcholine has been studied on the isolated guinea pig seminal vesicle. The results have been interpretated to indicate the relative potency of the antagonists with respect to antagonism of a given spasmogen, and, also, the relative specificity a single antagonist exhibits in antagonizing the various spasmogens.

All aryl-haloalkylamines studied were found to block the effects of epinephrine, nor-epinephrine, and histamine on the seminal vesicle. The effect of the blocking agents on the acetylcholine induced spasm was inconstant; N-ethyl-N-(2-chloroethyl)-benzhydrylamine·HCl (SY-2) and N-(2-chloroethyl)-dibenzylamine· HCl (Dibenamine) had no effect in non-spasmogenic amounts. However, N-ethyl-N-(2-bromoethyl)-1-naphthalene-methylamine-HBr (SY-28) and 2-(2-biphenyloxy)-2'chlorotriethylamine·HCl (SY-8) antagonized acetylcholine, albeit in doses considerably above those required of atropine sulfate; and N-ethyl-N-(2-chloroethyl)-9-fluorenamine·HCl (SY-21) potentiated acetylcholine-induced spasm.

N-ethyl-N-(2-chloroethyl)-9-fluorenamine (SY-21) was five times as potent as Dibenamine in antagonizing epinephrine, although N-ethyl-N-(2-chloroethyl)-benzhydrylamine (SY-2) was more discriminating in this regard since 44 times the quantity of drug was required to block histamine to the same degree as epinephrine. In this respect SY-21 and Dibenamine were 20 and 13 times as discriminating, respectively.

No parallelism existed among these drugs between the relative order of potency with respect to antagonism of epinephrine, histamine, or acetylcholine, while such a relationship was found to exist between epinephrine and norepinephrine.

The specificity demonstrated with atropine against acetyicholine and pyranisamine against histamine agree with those reported by Schild, who employed the guinea pig ileum. The use of the seminal vesicle, however, has the added advantage in that a broader spectrum of drug antagonism can be studied on a single test object.

Submitted on June 18, 1952







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.